Madam Chair, I'm not here to convince anyone but to explain our process and how we make our recommendations. This is through a rigorous process of looking at the evidence.
As I said, we looked at all of the different types of studies and put all that together. We looked at the studies informing on the values and preferences of patients and put that together. The decision is not made by one person but by the task force as a whole, which can look comprehensively at all that data.
What I can say to a woman diagnosed in her forties—and I have had patients diagnosed in their forties—is that this is such an awful diagnosis to have. In my opening statement, I related to you the number. I told you that when we look at women ages 40 to 49 and screen them for 10 years, we see that one out of 1,000 will not die of breast cancer because she was screened. Maybe that was her. That's a possibility.